Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
<p>Abstract</p> <p>Background</p> <p>Use of gonadotropin-releasing hormone (GnRH) agonists has become popular for virtually all stages of prostate cancer. We hypothesized that some men receive these agents after only a limited work-up for their cancer. Such cases may be...
Saved in:
Main Authors: | Kuo Yong-fang (Author), Goodwin James S (Author), Shahinian Vahakn B (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2008-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014) -
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014) -
Progress in Clinical Research on Gonadotropin-Releasing Hormone Receptor Antagonists for the Treatment of Prostate Cancer
by: Liu YF, et al.
Published: (2021) -
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
by: Francesca Poggio, et al.
Published: (2019) -
Comparison of the clinical outcome of frozen-thawed embryo transfer with and without pretreatment with a gonadotropin-releasing hormone agonist
by: Jieun Kang, et al.
Published: (2018)